Vulnerability Details : CVE-2022-3911
The iubenda WordPress plugin before 3.3.3 does does not have authorisation and CSRF in an AJAX action, and does not ensure that the options to be updated belong to the plugin as long as they are arrays. As a result, any authenticated users, such as subscriber can grant themselves any privileges, such as edit_plugins etc
Vulnerability category: Cross-site request forgery (CSRF)
Products affected by CVE-2022-3911
- cpe:2.3:a:iubenda:iubenda-cookie-law-solution:*:*:*:*:*:wordpress:*:*
Exploit prediction scoring system (EPSS) score for CVE-2022-3911
0.08%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 33 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2022-3911
| Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
|---|---|---|---|---|---|---|
|
8.8
|
HIGH | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H |
2.8
|
5.9
|
NIST |
CWE ids for CVE-2022-3911
-
The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor.Assigned by: contact@wpscan.com (Secondary)
-
The web application does not, or can not, sufficiently verify whether a well-formed, valid, consistent request was intentionally provided by the user who submitted the request.Assigned by:
- contact@wpscan.com (Primary)
- nvd@nist.gov (Secondary)
-
The product does not perform an authorization check when an actor attempts to access a resource or perform an action.Assigned by:
- contact@wpscan.com (Primary)
- nvd@nist.gov (Secondary)
-
The product performs an authorization check when an actor attempts to access a resource or perform an action, but it does not correctly perform the check. This allows attackers to bypass intended access restrictions.Assigned by: nvd@nist.gov (Primary)
References for CVE-2022-3911
-
https://wpscan.com/vulnerability/c47fdca8-74ac-48a4-9780-556927fb4e52
Just a moment...Exploit;Third Party Advisory
Jump to